SchalkLouw

Top5 oversold/overbought according to RSI & Richemont

JSE:CFR   COMPAGNIE FINANCIERE RICHEMONT SA
This week, the most noticeable thing to point out is the fact that 4 out of the top 5 most “overbought” companies are all Platinum mines. With the recent pullback in the Platinum price (in USD) and somewhat stronger Rand, I will caution any long positions in all four these mines over the shorter term.

Oversold:

Prosus 28
Ascendis Health 29
Richemont 30
Rhodes Food 31
Cashbuild 31

Overbought:

Northam Platinum 77
Capitec Bank 76
Royal Bafokeng Platinum 76
Impala Platinum 75
Anglo American Platinum 71

This week I want to spend some time on Richemont. First, my disclaimer. I like this company and is personally invested. I bought Richemont just below R100/share in November last year (http://oldoak.co.za/wp/index.php/2018/11/16/get-to-know-your-jse-companies-compagnie-financiere-richemont-jse-cfr/) and recently sold half the position just over R120/share as we felt the share price was somewhat “overvalued”. Would I buy it back now?

We still believe that Richemont is a quality business, and if you don’t own any, could use these “oversold” levels to buy for example, half of your total portfolio weight. The 50-day moving average is still pointing downward, which indicates that the trend is still very much downward. Should we see further weakness, we could get some support at R97.60, where I would look to buy back the other half of my position.

Should we see a breakthrough R97.60 levels, we could see the share price seeking support at R92.50. Short-term traders would most probably use this level as their stop-loss as a break and close below these levels, breaking a 3-year support line.

Should we see a recovery in the share price from current levels, could see resistance firstly at the 50-day moving average (R107.52), with, next resistance being the 200-day moving average (R116.64).


Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.